Biocatalytic Depletion of Tumorigenic Energy Sources Driven by Cascade Reactions for Efficient Antitumor Therapy

Angew Chem Int Ed Engl. 2022 Oct 17;61(42):e202204584. doi: 10.1002/anie.202204584. Epub 2022 Sep 12.

Abstract

Glucose and lactate play important roles for tumor growth. How to simultaneously deprive tumors of glucose and lactate is a big challenge. We have developed a cascade catalytic system (denoted as FPGLC) based on fluorinated polymer (FP) with co-loading of glucose oxidase (GOx), lactate oxidase (LOx), and catalase (CAT). GOx and LOx deprive glucose and lactate, respectively, resulting in abundant hydrogen peroxide (H2 O2 ) generation. Meanwhile, CAT catalyzes H2 O2 into O2 , which not only promotes catalytic reactions of GOx and LOx for consuming more glucose and lactate, but also alleviates tumor hypoxia. Benefiting from the excellent cross-membrane and transmucosal penetration capacities of FP, FPGLC rapidly accumulated in tumors and subsequently mediated enhanced cascade catalytic therapy under the guidance of photoacoustic imaging. These results demonstrate that the dual depletion of glucose and lactate with O2 supply is a promising strategy for efficient antitumor starvation therapy.

Keywords: Antitumor Therapy; Cascade Catalytic Reactions; Fluorinated Polymers; Glucose Depletion; Lactate Depletion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catalase
  • Cell Line, Tumor
  • Fluorocarbon Polymers
  • Glucose
  • Glucose Oxidase
  • Humans
  • Hydrogen Peroxide
  • Lactates
  • Nanoparticles*
  • Neoplasms* / pathology

Substances

  • Fluorocarbon Polymers
  • Lactates
  • Hydrogen Peroxide
  • Glucose Oxidase
  • Catalase
  • Glucose